Skip to content
Neurosoft Bioelectronics logo — Soft Minimally Invasive Brain Computer Interfaces

Neurosoft Bioelectronics

Soft Minimally Invasive Brain Computer Interfaces

Founded 2020 Switzerland Geneva, Switzerland 25 employees Seed Total: $10.46M Health Care, Medical Devices

General Information

Company Name Neurosoft Bioelectronics
Founded Year 2020
Location Switzerland Geneva, Switzerland
Employees 25
Industries Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Neurosoft Bioelectronics. To contact Neurosoft Bioelectronics, visit neurosoft-bio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neurosoft Bioelectronics compare?

A PDF of Neurosoft Bioelectronics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neurosoft Bioelectronics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Neurosoft Bioelectronics

Neurosoft Bioelectronics is pioneering the development of soft implantable brain computer interfaces with the slogan "Soft implantable brain computer interfaces". The company was founded in 2019 and is headquartered in Switzerland. Their focus on the Health Care industry aligns with their mission to enhance patient care for individuals suffering from neurological disorders. At the core of their innovation is the creation of soft implantable electrodes designed to interface with the nervous system. The unique technology developed by Neurosoft Bioelectronics enables the production of highly compliant neural interfaces, allowing for long-term bio-integration within the body. This breakthrough opens up new therapeutic possibilities, ultimately improving patient outcomes. Their latest milestone, a grant investment received on 28 April 2023 from Innosuisse, signifies a strong validation of their groundbreaking work. Neurosoft Bioelectronics is poised to make significant contributions in the field of neurological treatment with their innovative approach to neural interfaces.

Business keywords: Neurology, Neurological disorders, Brain computer interfaces, Implantable electrodes, Bio-integration, Neural interfaces, Medical technology, Neurological care, Therapeutic outcomes, Bioelectronics

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $7.50M 4
Connecticut Innovations, IAG Capital Partners +2
20 May 2026
Grant Undisclosed 1
Innosuisse
28 Apr 2023
Grant Fr.2.55M 1
European Innovation Council
29 Mar 2022
Convertible Note Fr.100.00K 1
FONGIT Innovation Fund
17 Dec 2021
Seed Round Fr.150.00K 1
Venture Kick
28 Jan 2021
Non Equity Assistance Undisclosed 1
MassChallenge
21 Oct 2020
Grant Fr.150.00K 1
>>venture>> Startup Competition
02 Jun 2020
Grant Fr.10.00K 1
Venture Kick
28 Jan 2020

Neurosoft Bioelectronics Alternatives & Competitors

View All Alternatives
Neurosoft Bioelectronics vs
Axoft
Axoft United States

Redefining health with seamless neural interfaces.

Non Equity Assistance
28 employees
Health Care, Health and Wellness
Neurosoft Bioelectronics vs
Bioinduction
Bioinduction United Kingdom

Novel Adaptive "cranialized Brain Pacemaker” platform to treat chronic neurodegenerative and cerebro...

Grant
6 employees
Health Care, Medical Devices
Neurosoft Bioelectronics vs
CorTec
CorTec Germany

Communicating with the Nervous System - for the Cure of Disease

Grant
67 employees
Health Care, Medical Devices

FAQ About Neurosoft Bioelectronics

Soft Minimally Invasive Brain Computer Interfaces
Neurosoft Bioelectronics was founded in 2020.
Neurosoft Bioelectronics is headquartered in Geneva, Switzerland.
Neurosoft Bioelectronics operates in Health Care and Medical Devices. Its work centres on Neurology, Neurological disorders, Brain computer interfaces and Implantable electrodes.
Neurosoft Bioelectronics has approximately 25 employees.
Neurosoft Bioelectronics has completed 8 funding rounds, raising a total of $10.46M. The latest funding stage is Seed.
Top alternatives and competitors to Neurosoft Bioelectronics include Axoft, Bioinduction, CorTec, INBRAIN Neuroelectronics, Paradromics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurosoft Bioelectronics and Axoft are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neurosoft Bioelectronics, https://bouncewatch.com/company/neurosoft-bioelectronics, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout